Skip to main content
Claret Medical's TAVR embolic protection system wins FDA clearance

Claret Medical has obtained clearance from the FDA through its de novo classification pathway for the Sentinel Cerebral Protection System, a cerebral protection device designed to capture embolic debris during transcatheter aortic-valve replacement using a proximal and distal filter. The company said it is working with the CMS to get a new technology add-on payment for the device.

Full Story: